NCT00002136View on ClinicalTrials.gov

A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Sarcoma, KaposiHIV Infections
Interventions
DRUG

Tecogalan sodium

Trial Locations (1)

78229

Cancer Therapy Research Ctr, San Antonio

Sponsors
All Listed Sponsors
lead

Daiichi Pharmaceuticals

INDUSTRY

NCT00002136 - A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days | Biotech Hunter | Biotech Hunter